Zobrazeno 1 - 10
of 20
pro vyhledávání: '"W A Mellink"'
Autor:
M. B. Van't Veer, I C Schouten, H. V. Van Kamp, Hanneke C. Kluin-Nelemans, J M Raemaekers, W A Mellink
Publikováno v:
Annals of Hematology, 73(6), 273-277. SPRINGER
Purpose: To analyze whether, in addition to survival, and disease-free survival progression-free interval after transplantation would be longer than the last progression-free interval before transplantation, supporting the argument that high-dose the
Autor:
H, Flechtner, J U, Rüffer, M, Henry-Amar, W A, Mellink, M, Sieber, C, Fermé, H, Eghbali, A, Josting, V, Diehl
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 9
Previous reports from available trials have dealt with negative long-term sequelae in Hodgkin's disease (HD) survivors. There is, however, a lack of longitudinal data showing the correlation between outcome and various treatment-related variables and
Autor:
I C, Schouten, J J, Raemaekers, H C, Kluin-Nelemans, H, van Kamp, W A, Mellink, M B, van't Veer
Publikováno v:
Annals of hematology. 73(6)
To analyze whether, in addition to survival, and disease-free survival progression-free interval after transplantation would be longer than the last progression-free interval before transplantation, supporting the argument that high-dose therapy may
Autor:
E M, Noordijk, P, Carde, A M, Mandard, W A, Mellink, M, Monconduit, H, Eghbali, U, Tirelli, J, Thomas, R, Somers, N, Dupouy
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 5
In this phase III trial, 770 patients with clinical stage I-II Hodgkin's disease (HD) have been enrolled since November 1988. Preliminary results are given for the 605 (79%) patients who have completed their initial therapy. Patients were grouped acc
Autor:
José Thomas, J. M. V. Burgers, P. Y. Dietrich, Jacques Bosq, Michel Henry-Amar, J M Raemaekers, W A Mellink, Evert M. Noordijk, N Dupouy, S Bodis
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 11(2)
PURPOSE The great majority of relapses after the treatment for early-stage Hodgkin's disease are observed within 4 to 5 years after treatment completion. This study describes the characteristics and outcome of patients who had late relapses, which wa
Autor:
A, Hagenbeek, W A, Mellink
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 135(47)
Publikováno v:
Cancer. 67(7)
The role of routine mammography was assessed in the early detection of asynchronous contralateral breast cancer (ACBC). The breast cancer patient populations of two cities, Nijmegen and Eindhoven, The Netherlands, which were subjected to a well-defin
Autor:
Robert Kaptein, W. A. Mellink
Publikováno v:
Organic Magnetic Resonance. 13:279-281
The resonances in the 13C NMR spectra of 1,2,5,6-tetramethyl-3,4-dimethylenetricyclo[3.1.0.02,6]hexane and the corresponding enone and dione have been assigned. The rotation energy barriers of the methyl groups have been determined from 13C spin-latt
Publikováno v:
RSC Advances; 2019, Vol. 9 Issue 61, p35735-35750, 16p
Publikováno v:
Journal of Chemical Physics; 2018, Vol. 148 Issue 9, p1-1, 1p, 1 Diagram, 4 Charts, 6 Graphs